Demand for concierge and functional medicine is surging, fueled by the GLP-1 boom and by healthcare costs increasingly shifting onto consumers. Fifth Third Securities managing director Chris Dorn describes this space, also known as “precision health,” as a consultative healthcare model where patients get more time with their physician and access to treatments standard primary care won’t provide. In this conversation with McGuireWoods partner and host Geoff Cockrell, Chris digs into the details investors weigh: how much GLP-1 exposure sinks a deal’s appeal, and who actually buys these businesses once they reach real scale.

Tune in for where the opportunity — and the traps — lie in one of healthcare’s fastest-emerging markets.